COVID-19 Reveals Weakness Of Global Health Financing Systems, Says New WHO Expenditure Report 11/12/2020 Raisa Santos The combined health and economic shocks triggered by COVID-19 have revealed profound weaknesses in health systems, with direct consequences on the future of healthcare, says a new World Health Organisation report on global health financing systems. “COVID-19 has revealed [the] underlying weakness of country and global health financing systems. There needs to be a proactive […] Continue reading -> First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Economic Benefits Of Equitable Vaccine & Medicines Distribution Would Be 12 Times Costs to Donor Countries, Says Study 04/12/2020 Raisa Santos The economic benefits to the economies of ten high income countries being asked to support the equitable, worldwide distribution of COVID-19 vaccines, treatments and tests would be 12 times the costs, a new report has found. The study, undertaken by the global political risk research firm Eurasia Group, on behalf of the Bill and Melinda […] Continue reading -> The Americas At Risk For COVID-19 Surge Due To Holiday Travel – WHO Also Calls Out Brazilian and Mexican Leaders 30/11/2020 J Hacker & Madeleine Hoecklin WHO officials have expressed concern about yet another spike in COVID-19 infections and deaths across the Americas, following the Thanksgiving holiday on Thursday, and in the run-up to Christmas – echoing concerns already being expressed by United States health authorities. The US has reported 2 million new COVID-19 cases in the past 2 weeks: a […] Continue reading -> COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> The COVID-19 and NCD Syndemic: Experiences From Rwanda, the UK, and India 20/11/2020 Madeleine Hoecklin COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday. However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Posts navigation Older postsNewer posts
First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Economic Benefits Of Equitable Vaccine & Medicines Distribution Would Be 12 Times Costs to Donor Countries, Says Study 04/12/2020 Raisa Santos The economic benefits to the economies of ten high income countries being asked to support the equitable, worldwide distribution of COVID-19 vaccines, treatments and tests would be 12 times the costs, a new report has found. The study, undertaken by the global political risk research firm Eurasia Group, on behalf of the Bill and Melinda […] Continue reading -> The Americas At Risk For COVID-19 Surge Due To Holiday Travel – WHO Also Calls Out Brazilian and Mexican Leaders 30/11/2020 J Hacker & Madeleine Hoecklin WHO officials have expressed concern about yet another spike in COVID-19 infections and deaths across the Americas, following the Thanksgiving holiday on Thursday, and in the run-up to Christmas – echoing concerns already being expressed by United States health authorities. The US has reported 2 million new COVID-19 cases in the past 2 weeks: a […] Continue reading -> COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> The COVID-19 and NCD Syndemic: Experiences From Rwanda, the UK, and India 20/11/2020 Madeleine Hoecklin COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday. However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Posts navigation Older postsNewer posts
Economic Benefits Of Equitable Vaccine & Medicines Distribution Would Be 12 Times Costs to Donor Countries, Says Study 04/12/2020 Raisa Santos The economic benefits to the economies of ten high income countries being asked to support the equitable, worldwide distribution of COVID-19 vaccines, treatments and tests would be 12 times the costs, a new report has found. The study, undertaken by the global political risk research firm Eurasia Group, on behalf of the Bill and Melinda […] Continue reading -> The Americas At Risk For COVID-19 Surge Due To Holiday Travel – WHO Also Calls Out Brazilian and Mexican Leaders 30/11/2020 J Hacker & Madeleine Hoecklin WHO officials have expressed concern about yet another spike in COVID-19 infections and deaths across the Americas, following the Thanksgiving holiday on Thursday, and in the run-up to Christmas – echoing concerns already being expressed by United States health authorities. The US has reported 2 million new COVID-19 cases in the past 2 weeks: a […] Continue reading -> COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> The COVID-19 and NCD Syndemic: Experiences From Rwanda, the UK, and India 20/11/2020 Madeleine Hoecklin COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday. However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Posts navigation Older postsNewer posts
The Americas At Risk For COVID-19 Surge Due To Holiday Travel – WHO Also Calls Out Brazilian and Mexican Leaders 30/11/2020 J Hacker & Madeleine Hoecklin WHO officials have expressed concern about yet another spike in COVID-19 infections and deaths across the Americas, following the Thanksgiving holiday on Thursday, and in the run-up to Christmas – echoing concerns already being expressed by United States health authorities. The US has reported 2 million new COVID-19 cases in the past 2 weeks: a […] Continue reading -> COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> The COVID-19 and NCD Syndemic: Experiences From Rwanda, the UK, and India 20/11/2020 Madeleine Hoecklin COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday. However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Posts navigation Older postsNewer posts
COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> The COVID-19 and NCD Syndemic: Experiences From Rwanda, the UK, and India 20/11/2020 Madeleine Hoecklin COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday. However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Posts navigation Older postsNewer posts
Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> The COVID-19 and NCD Syndemic: Experiences From Rwanda, the UK, and India 20/11/2020 Madeleine Hoecklin COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday. However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Posts navigation Older postsNewer posts
AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> The COVID-19 and NCD Syndemic: Experiences From Rwanda, the UK, and India 20/11/2020 Madeleine Hoecklin COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday. However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Posts navigation Older postsNewer posts
Regeneron Antibody Treatment Granted Emergency Authorization By FDA 23/11/2020 Madeleine Hoecklin The US Food and Drug Administration (FDA) authorised an experimental antibody cocktail produced by Regeneron for emergency use on Saturday. The treatment, consisting of the two antibodies casirivimab and imdevimab, will be limited to patients aged 12 and over with positive SARS-CoV2 test results and at risk of developing severe COVID-19. Clinical trial results showed […] Continue reading -> The COVID-19 and NCD Syndemic: Experiences From Rwanda, the UK, and India 20/11/2020 Madeleine Hoecklin COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday. However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Posts navigation Older postsNewer posts
The COVID-19 and NCD Syndemic: Experiences From Rwanda, the UK, and India 20/11/2020 Madeleine Hoecklin COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday. However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading -> Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Posts navigation Older postsNewer posts
Achieving Health Equity Is Restricted By Politicians’ Reluctance To Act Upon Science 19/11/2020 Paul Adepoju The current power dynamics in global health are a barrier to achieving health equity, partly because too many high-profile politicians are simply reluctant to listen to, or act upon, scientific evidence, and partly because of countries and institutions that wield disproportionate influence in today’s global health architecture aren’t willing to relinquish their power: a left-over […] Continue reading -> Posts navigation Older postsNewer posts